Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case study

被引:18
|
作者
Lemaitre, Joseph Chadi [1 ,2 ]
Pasetto, Damiano [2 ]
Zanon, Mario [3 ]
Bertuzzo, Enrico [2 ]
Mari, Lorenzo [4 ]
Miccoli, Stefano [5 ]
Casagrandi, Renato [4 ]
Gatto, Marino [4 ]
Rinaldo, Andrea [1 ,6 ]
机构
[1] Ecole Polytech Fed Lausanne, Lab Ecohydrol, Lausanne, Switzerland
[2] Univ Ca Foscari Venezia, Dipartimento Sci Ambientali Informat & Stat, Venice, Italy
[3] Scuola IMT Alti Studi Lucca, Lucca, Italy
[4] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy
[5] Politecn Milan, Dipartimento Meccan, Milan, Italy
[6] Univ Padua, Dipartimento ICEA, Padua, Italy
基金
瑞士国家科学基金会;
关键词
STRATEGIES; MODEL; VACCINATION; AGE;
D O I
10.1371/journal.pcbi.1010237
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
While campaigns of vaccination against SARS-CoV-2 are underway across the world, communities face the challenge of a fair and effective distribution of a limited supply of doses. Current vaccine allocation strategies are based on criteria such as age or risk. In the light of strong spatial heterogeneities in disease history and transmission, we explore spatial allocation strategies as a complement to existing approaches. Given the practical constraints and complex epidemiological dynamics, designing effective vaccination strategies at a country scale is an intricate task. We propose a novel optimal control framework to derive the best possible vaccine allocation for given disease transmission projections and constraints on vaccine supply and distribution logistics. As a proof-of-concept, we couple our framework with an existing spatially explicit compartmental COVID-19 model tailored to the Italian geographic and epidemiological context. We optimize the vaccine allocation on scenarios of unfolding disease transmission across the 107 provinces of Italy, from January to April 2021. For each scenario, the optimal solution significantly outperforms alternative strategies that prioritize provinces based on incidence, population distribution, or prevalence of susceptibles. Our results suggest that the complex interplay between the mobility network and the spatial heterogeneities implies highly non-trivial prioritization strategies for effective vaccination campaigns. Our work demonstrates the potential of optimal control for complex and heterogeneous epidemiological landscapes at country, and possibly global, scales.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Estimation and optimal control of the multiscale dynamics of Covid-19: a case study from Cameroon
    David Jaurès Fotsa-Mbogne
    Stéphane Yanick Tchoumi
    Yannick Kouakep-Tchaptchie
    Vivient Corneille Kamla
    Jean-Claude Kamgang
    Duplex Elvis Houpa-Danga
    Samuel Bowong-Tsakou
    David Bekolle
    Nonlinear Dynamics, 2021, 106 : 2703 - 2738
  • [32] Mathematical Analysis of Optimal Cost-effective Control of COVID-19: A Case Study
    Abidemi, Afeez
    Fatoyinbo, Hammed Olawale
    2021 INTERNATIONAL CONFERENCE ON DECISION AID SCIENCES AND APPLICATION (DASA), 2021,
  • [33] Optimal age-specific vaccination control for COVID-19: An Irish case study
    Zavrakli, Eleni
    Parnell, Andrew
    Malone, David
    Duffy, Ken
    Dey, Subhrakanti
    PLOS ONE, 2023, 18 (09):
  • [34] Correction to: Optimal control analysis of COVID-19 vaccine epidemic model: a case study
    Arshad Alam Khan
    Saif Ullah
    Rohul Amin
    The European Physical Journal Plus, 137
  • [35] Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy
    Menniti-Ippolito, Francesca
    Mele, Alfonso
    Da Cas, Roberto
    De Masi, Salvatore
    Chiarotti, Flavia
    Fabiani, Massimo
    Baglio, Giovanni
    Traversa, Giuseppe
    Colavita, Francesca
    Castilletti, Concetta
    Salomone, Mario
    Zoccali, Carmine
    Messa, Piergiorgio
    JOURNAL OF NEPHROLOGY, 2023, 36 (07) : 2013 - 2022
  • [36] Cutaneous Reactions to COVID-19 Vaccines in a Monocentric Study: A Case Series
    Cantisani, Carmen
    Chello, Camilla
    Grieco, Teresa
    Ambrosio, Luca
    Kiss, Norbert
    Tammaro, Antonella
    Tosti, Giulio
    Paolino, Giovanni
    Pellacani, Giovanni
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [37] On willingness to pay for Covid-19 vaccines: a case study from India
    Das, Upasak
    Rathore, Udayan
    Pal, Rupayan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (12) : 4904 - 4913
  • [38] Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy
    Francesca Menniti-Ippolito
    Alfonso Mele
    Roberto Da Cas
    Salvatore De Masi
    Flavia Chiarotti
    Massimo Fabiani
    Giovanni Baglio
    Giuseppe Traversa
    Francesca Colavita
    Concetta Castilletti
    Mario Salomone
    Carmine Zoccali
    Piergiorgio Messa
    Journal of Nephrology, 2023, 36 (7) : 2013 - 2022
  • [39] Spatial Optimization to Improve COVID-19 Vaccine Allocation
    Scroggins, Stephen
    Goodson, Justin
    Afroze, Tasnova
    Shacham, Enbal
    VACCINES, 2023, 11 (01)
  • [40] COVID-19 Vaccines
    不详
    US PHARMACIST, 2021, 46 (02)